News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
272
Sources here
22
Companies here
11
Search results Stored financial headlines

Active search

272 matching headlines

Ticker or company: OSMMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm's total Q2 turnover reached £8.4 billion, marking a 5% increase year-over-year at constant exchange rates (CER), while Core operating profit climbed …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dodge & Cox reports 4.3% GSK plc (GSK) stake in Schedule 13G/A

Dodge & Cox, an investment manager, has reported a 4.3% beneficial ownership stake in GSK plc, as detailed in an Amendment No. 3 to Schedule 13G filing. The filing indicates that Dodge & Cox beneficially owns 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares, …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MFS Blended Research International Equity Fund's GSK PLC(LSE:GSK) Holding History

MFS Blended Research International Equity Fund holds 1.57 million shares of GSK PLC (LSE:GSK), valued at £39.86 million, representing 0.85% of their portfolio. The fund acquired these shares at an average price of £20.07, and based on the current price of £18.57, has an …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Senior GSK plc (GSK) leaders acquire Ordinary Shares through Share Reward Plan

Several senior leaders and one closely associated person at GSK plc acquired Ordinary Shares under the company's Share Reward Plan on August 11, 2026. The acquisitions were made on the London Stock Exchange at a price of £19.3496 per share, with most individuals acquiring …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Kosmos Energy (KOS) a Great Value Stock Right Now?

Zacks Investment Research highlights Kosmos Energy (KOS) as a strong value stock, giving it a Zacks Rank #2 (Buy) and an A grade for Value. The article points to KOS's attractive P/B ratio of 0.79 and P/S ratio of 0.96, both favorable compared to …

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy Ltd. stock falls Wednesday, underperforms market

Kosmos Energy Ltd. (KOS) stock decreased by 1.95% on Wednesday, closing at $2.51. This performance lagged behind the overall market, with the NASDAQ Composite Index rising and the Dow Jones Industrial Average slightly falling. The decline ended a four-day winning streak for Kosmos Energy.

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to earnings forward of Cosmos Health Inc – DUS:V67A

This article provides financial data for Cosmos Health Inc (DUS:V67A) on the Dusseldorf Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It presents a data table with period values and changes, noting that the market is currently closed with no trades. The content …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GSK plc (GSK) president reports acquisition of notional ADS in savings plan

GSK plc reported that its President, Maya Martinez-Davis, acquired 9.016 notional American Depositary Shares (ADS) at $52.9600 per ADS on August 7, 2026. This transaction occurred on the New York Stock Exchange and was part of her GSK Executive Supplemental Savings Plan account. The …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy (KOS) Q2 2026 Earnings Call Transcript

Kosmos Energy discussed its Q2 2026 results, highlighting significant progress against its 2026 goals, including increased production from Jubilee and GTA, reduced operating costs, and a meaningful reduction in net debt. The company provided updates on its Ghana, GTA, and Gulf of America operations, …

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SCA secures US contract award with Kosmos Energy for an onshore umbilical storage carousel

Subsea Cable Assets (SCA) has won its first contract with Kosmos Energy to supply a newly designed 1000 t onshore umbilical storage carousel. This system will support umbilical storage and handling operations for an onshore project in Mobile, Alabama, USA, with delivery scheduled for …

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GSK Plc (GSK) Stock Analysis: Exploring A 9.66% Potential Upside In The Healthcare Giant

GSK Plc (GSK) shows a potential upside of 9.66% with a market capitalization of $106.07 billion and a forward P/E of 10.31, suggesting potential undervaluation. The company exhibits strong financial health with 5.30% revenue growth, a 33.38% ROE, and a 3.43% dividend yield. Analysts …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy (KOS) Following Q2 Results And Guidance Looks Undervalued

Kosmos Energy (KOS) is gaining investor attention after reporting strong Q2 earnings of US$184.78 million and increased production, resulting in a 177.78% year-to-date share price return. Despite past shareholder losses, the company is seen by many as undervalued, with a fair value estimated at …

KOS main company KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy (KOS) Is Down 7.8% After Return To Profitability On Higher Q2 Output – What's Changed

Kosmos Energy (KOS) reported a return to profitability in Q2 2026 with higher output, averaging 71,400 boepd, driven by the GTA ramp-up and new Jubilee wells. Despite this positive quarter and updated production guidance for Q3 and full-year 2026, the stock dropped 7.8%, indicating …

KOS main company KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Glaxosmithkline plc - ADR (GSK) News, Articles, Events & Latest Updates

This article provides recent news and updates concerning Glaxosmithkline plc (GSK), alongside other pharmaceutical companies. Key highlights include GSK beating Q2 earnings and revenue estimates and announcing a cost-saving plan, as well as news about Moderna's mRNA flu vaccine approval and other companies' financial …

GSK main company
Sharemaestro market context Price below Trend Line 52 weeks +26.3% · Next-week setup positive 55.6% GSK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kosmos Energy (NYSE:KOS) Upgraded to Buy at Wall Street Zen

Wall Street Zen has upgraded Kosmos Energy (NYSE:KOS) from a "hold" to a "buy" rating, despite a broader analyst consensus of "reduce" with an average price target of $2.53. The upgrade follows Kosmos Energy's recent quarterly earnings report where it surpassed EPS and revenue …

KOS main company
Sharemaestro market context Price above Trend Line 52 weeks +38.0% · Next-week setup negative 43.2% KOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cosmos Health Inc (COSM), noting that no earnings forecast score is currently available, but the Pharmaceuticals industry average is 7.86. Analysts have set an average price target of $3.00 for COSM, representing a significant upside. Key financial …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context